Rafael Amado's Net Worth

$4.26 Million

Estimate Recalculated Nov 7, 2024 04:53PM EST

Who is Rafael Amado

Rafael Amado has an estimated net worth of $4.26 Million. This is based on reported shares across multiple companies, which include Allogene Therapeutics, Inc., Adaptimmune Therapeutics PLC, Zai Lab Ltd, and Poseida Therapeutics, Inc..

SEC CIK

Rafael Amado's CIK is 0001662119

Past Insider Trading and Trends

2023 was Rafael Amado's most active year for acquiring shares with 6 total transactions. Rafael Amado's most active month to acquire stocks was the month of December. 2022 was Rafael Amado's most active year for disposing of shares, totalling 7 transactions. Rafael Amado's most active month to dispose stocks was the month of September. 2024 saw Rafael Amado paying a total of $85,716.90 for 250,624 shares, this is the most they've acquired in one year. In 2020 Rafael Amado cashed out on 26,290 shares for a total of $1,006,176.22, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Allogene Therapeutics, Inc.

EVP R&D
Updated Oct 11, 2022
Form 4
2.01%
10.66K
$11.83
-$100.10K
Oct 11, 2022
541.95K
Grant
Oct 07
Form 4
-1.66%
-8.97K
$11.06
-$99.20K
Oct 05, 2022
531.29K
Tax
Oct 03
Form 4
-0.37%
-2.00K
$11.97
-$23.94K
Aug 02, 2022
540.26K
Sale
ScheduledAug 02
Form 4
-0.37%
-2.00K
$11.44
-$22.88K
Jul 06, 2022
542.26K
Sale
ScheduledJul 05
Form 4
-0.37%
-2.00K
$11.18
-$22.36K
Jun 22, 2022
544.26K
Sale
ScheduledJun 21
Form 4
-2.06%
-11.50K
$7.40
-$85.09K
May 19, 2022
546.26K
Sale
May 19
Form 4
189.29%
605.95K
Mar 25, 2022
926.07K
Grant
Mar 23
Form 4
-1.59%
-5.17K
$7.71
-$39.85K
Mar 17, 2022
320.12K
Sale
Mar 15
Form 4
-3.43%
-11.51K
$24.35
-$280.19K
Oct 04, 2021
323.93K
Sale
Oct 01
Form 4
148.65%
200.53K
May 20, 2021
335.44K
Grant
May 18
Form 4
106.54%
117.23K
Mar 30, 2021
227.27K
Grant
Mar 26
Form 4
-2.48%
-2.80K
$38.05
-$106.47K
Mar 17, 2021
110.04K
Sale
Mar 15
Form 4
-12.90%
-16.54K
$39.40
-$651.51K
Oct 08, 2020
111.68K
Sale
ScheduledOct 07
Form 4
-7.07%
-9.75K
$36.37
-$354.66K
Oct 02, 2020
128.22K
Sale
Oct 01
Form 4
133.51%
140.40K
Mar 20, 2020
245.56K
Grant
Mar 18
Form 4
265.79K
Sep 05, 2019
265.79K
Grant
Sep 03
Form 3
Sep 05, 2019
Showing 17 results

Adaptimmune Therapeutics PLC

President, R&D
Updated Aug 07, 2019
Form 4
-39.05%
-11.04K
$2.06
-$22.75K
Aug 07, 2019
17.24K
Sale
Aug 06
Form 4
-37.84%
-3.03K
$5.37
-$16.26K
Jan 16, 2019
4.97K
Sale
Jan 14
Form 4
1.23M
Jan 08, 2019
1.23M
Grant
Jan 04
Form 4
678.72K
Aug 07, 2018
678.72K
Grant
Aug 06
Form 4
1.05M
Jan 17, 2018
1.05M
Grant
Jan 12
Form 4
2.07M
Jan 18, 2017
2.07M
Grant
Jan 13
Form 4
939.95K
Jan 20, 2016
939.95K
Grant
Jan 18
Form 3
Jan 04, 2016
96.00K
Showing 8 results

Zai Lab Ltd

See Remarks
Updated Aug 14, 2024
Form 4
-13.24%
-3.12K
$16.20
-$50.46K
Aug 14, 2024
20.42K
Sale
Aug 12
Form 4
-4.69%
-1.95K
$15.79
$55.12K
Apr 05, 2024
39.71K
Sale
Apr 03 - Apr 04
Form 4
198.23K
Apr 03, 2024
198.23K
Grant
Apr 01
Form 4
-11.24%
-2.54K
$18.86
-$47.98K
Mar 19, 2024
20.09K
Sale
Mar 15
Form 4
-15.37%
-19.36K
$26.30
-$509.17K
Jan 03, 2024
106.64K
Sale
Dec 29 - Jan 02
Form 4
134.78K
Apr 05, 2023
134.78K
Grant
Apr 03
Form 4
309.70K
Jan 03, 2023
309.70K
Grant
Dec 30
Form 3
Jan 03, 2023
Showing 8 results

Poseida Therapeutics, Inc.

Investor
Updated Jun 18, 2024
Form 4
119.59%
47.00K
Jun 18, 2024
86.30K
Grant
Jun 17
Form 4
94.50K
May 02, 2023
94.50K
Grant
May 01
Form 3
Apr 14, 2023
Showing 3 results